Reevaluating the Microbial Infection Link to Alzheimer's Disease

Lee Schnaider1, Zohar A Arnon1, Ehud Gazit1,2,3

  • 1Department of Molecular Microbiology and Biotechnology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.

Insights

Microbial infections may contribute to Alzheimer's disease (AD), a common dementia. While not proving causation, this emerging evidence warrants further investigation for potential new AD treatments.

Area of Science:

  • Neuroscience
  • Microbiology
  • Pathogenesis

Background:

  • Alzheimer's disease (AD) is the leading cause of dementia, with no effective preventative or disease-modifying treatments currently available.
  • The precise molecular mechanisms underlying AD pathogenesis remain incompletely understood.
  • A long-standing hypothesis suggesting a role for microbial infections in AD has recently gained significant attention due to accumulating evidence.

Purpose of the Study:

  • To provide a perspective on the implications of recent findings linking pathogenic microbes to AD.
  • To explore the interplay between molecular self-assembly, neurodegeneration, and antimicrobial peptides in the context of AD.
  • To propose an amendment to the existing amyloid cascade hypothesis for AD.

Main Methods:

  • Review and synthesis of current research on microbial associations with Alzheimer's disease.
  • Analysis of the interplay between microbial factors, protein self-assembly, and neurodegenerative processes.
  • Conceptual framework development for an updated amyloid cascade hypothesis.

Main Results:

  • Growing evidence suggests associations between various pathogenic microbes and Alzheimer's disease.
  • These findings highlight connections between microbial presence, neurodegeneration, and the body's antimicrobial peptide responses.
  • The study frames these associations within the broader context of molecular self-assembly.

Conclusions:

  • The association between microbial infections and AD, while not yet causal, is significant and warrants intensive investigation.
  • Further research into the microbial infection-AD hypothesis may reveal novel therapeutic targets for Alzheimer's disease.
  • An amended amyloid cascade hypothesis incorporating microbial roles is proposed.